Background: Although chemotherapy-induced vocal-fold motion impairment was first
reported in 1971, there are few reports. Herein, we describe a case in which life-threatening …

An 86-year-old woman with diffuse large B-cell lymphoma developed left vocal fold
immobility with dysphonia and aspiration after six cycles of rituximab, cyclophosphamide …

Objective: Chemotherapy-induced vocal fold motion impairment (CIVFMI) is a rare
complication of cancer therapy with potential for airway compromise. The objective of this …

Glottic insufficiency is commonly observed in patients with vocal cord paralysis, vocal cord
paresis, and vocal cord atrophy, and it can cause symptoms such as hoarseness, difficulty …

Purpose To compare pulmonary and swallow outcomes of injection laryngoplasty when
performed in the acute versus subacute setting in head & neck and thoracic cancer patients …

Vocal cord paralysis after administration of the chemotherapeutic agent vincristine is a rare
occurrence. Most occurrences are bilateral. Of the 24 cases referenced in this article, 19 are …

Background Vincristine, a type of vinca alkaloid, is widely used in the treatment of various
childhood and adult malignancies. A well-known side effect of vincristine is its neurotoxicity …

Introduction: Chemotherapy is a rare cause of iatrogenic vocal fold dysfunction. It has been
reported in three main classes of chemotherapy agents and often occurs during the …

Abstract Objectives/Hypothesis: To review the clinical results of office‐based injection
laryngoplasty with two different therapeutic materials in patients with vocal fold paralysis and …

Background Unilateral vocal cord paralysis may result from nerve compression by tumors or
direct nerve injuries during tumor resections, which can cause dysphonia or dysphagia, and …